Skip to content

Quality of orthodontic treatment with straightwire or standard edgewise appliances

Clinical outcomes of orthodontic extraction treatment with pre-adjusted versus standard edgewise appliances: a retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN13048456
Enrollment
50
Registered
2018-05-29
Start date
2018-05-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Most orthodontic malocclusions can be effectively treated with comprehensive fixed appliance treatment, due to the ability of the latter to perform controlled tooth movements in all three planes of space. Often, severe arch length discrepancies or several dental/skeletal malocclusions necessitate the incorporation of dental extractions in the orthodontic treatment plan. Oral Health

Interventions

Patient clinical documentation is consistently taken by all orthodontists both before insertion of the orthodontic appliances and directly after their removal (around 18-60 months after insertion). Th

Sponsors

University of Zurich
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Any ethnicity or race 2. Male or female 3. Class I, Class II, or Class III malocclusion 4. Full complement of teeth excluding the third molars 5. No previous orthodontic treatment 6. No dentofacial deformities or clefts 7. Complete set of diagnostic records With the following treatment characteristics to control for factors that might influence treatment outcome or duration: 1. One phase treatment with labial fixed appliances in both arches (no two-phase treatment) 2. Bilateral extraction of a premolar in one or two jaws (either 2- or 4-premolars extracted) 3. No temporary anchorage devices of any form 4. No orthognathic surgery 5. No dental trauma 6. No impacted canines 7. Complete set of treatment records

Exclusion criteria

Exclusion criteria: Does not meet inclusion criteria

Design outcomes

Secondary

MeasureTime frame
The secondary outcomes will include each of the separate components of the ABO OGS score that is used as a summary in the primary outcome. Additionally, the treatment duration will be also extracted from the patient files and be used together with the ABO OGS to assess treatment efficacy. As treatment durations are expected to differ between the two centers, we might consider normalizing treatment durations within each center with the average duration of each center.

Primary

MeasureTime frame
The ABO OGS score will be evaluated using all its 8 components: alignment, marginal ridges, buccolingual inclination, overjet, occlusal contacts, occlusal relationships, interproximal contacts, and root angulation. This is measured from the patients’ post-treatment documentation (stone cast models of the occlusion and x-ray) using a specific checklist/form provided by ABO. The overall cumulative score for all ABO OGS categories will be used as primary outcome. The principal investigator (S.N.P.) has prior to initiation of the study completed the necessary calibration process as instructed by the ABO. All measurements will be obtained using the special ABO gauge provided with the calibration kit. The principal investigator has extensive experience in cephalometric analyses and their assessment for research purposes. The primary outcome of this study will be the overall ABO OGS score in a continuous scale (expected to be normally-distributed). Reliability of the method Descriptive and inferential statistics will be performed to detect both random and systematic errors of the method. Initially, Dahlberg's formula will be used to assess intra examiner repeatability. With the aid of a table of random numbers, 10 patients will be randomly selected and will be re-evaluated 10 days later by the same examiner (S.N.P.) and also by a second examiner. Next, the intraclass correlation coefficient and the Bland-Altman limits of agreement [Bland and Altman, 1986] will be used to evaluate interexaminer agreement.

Countries

Norway, Switzerland

Contacts

Public ContactSpyridon Papageorgiou
snpapage@gmail.com+41 (0)44 634 32 87

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026